Condition: Multiple Myeloma · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to evaluate how well JNJ-79635322 works when compared with teclistamab.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Highlands Oncology Group | Springdale, Arkansas, United States | Recruiting |
| Valkyrie Clinical Trials | Los Angeles, California, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Nebraska Cancer Specialists | Omaha, Nebraska, United States | Recruiting |
| Astera Cancer Care | East Brunswick, New Jersey, United States | Recruiting |
| Christus St. Vincent Regional Cancer Center | Santa Fe, New Mexico, United States | Recruiting |
| Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island | Mineola, New York, United States | Recruiting |
| Laura and Isaac Perlmutter Cancer Center NYU ACC | New York, New York, United States | Recruiting |
| New York Cancer and Blood Specialists | Shirley, New York, United States | Recruiting |
| Gabrail Cancer Center | Canton, Ohio, United States | Recruiting |
| The Christ Hospital | Cincinnati, Ohio, United States | Recruiting |
| St Vincent s Hospital Sydney | Darlinghurst, Australia | Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07518186